Navigation Links
Osseon Signs International Distribution Agreement With MBA Incorporado
Date:9/22/2009

SANTA ROSA, Calif., Sept. 22 /PRNewswire/ -- Osseon Therapeutics, Inc., a Santa Rosa, California, manufacturer of spinal medical devices for the minimally invasive treatment of spinal compression fractures, today announced it has signed a five-year agreement with MBA Incorporado, SL to distribute Osseon's suite of products in the European and South American markets. MBA is a leading medical device marketing and distribution organization and specializes in the sale of products used for treatment of the spine. MBA is the largest private independent distributor of orthopaedic devices in Europe, generating more than $100 million in total sales in 2008.

Osseon's product line features the Osseoflex and Osseoperm. These products combine to form a unique new procedure termed Osseoplasty to treat painful acute fractures of the vertebrae seen increasingly in older individuals with osteoporosis and osteo-traumatic injuries.

Osseoflex is a steerable and curvable needle that can access the majority of the vertebral body from a single percutaneous access point. The Osseoperm system is customized for delivering optimal viscosity cement and precise cement placement through the Osseoflex needle. The Osseoplasty procedure provides rapid stabilization of vertebral fractures and significant pain relief in most patients within the same day.

MBA will distribute Osseon's devices to physicians and hospitals throughout the European Union, including the United Kingdom, Germany, Spain, Portugal, Italy, Greece, Austria, Switzerland, Scandinavia, France, Benelux, Turkey and Germany, as well as Latin America.

"Osseon is excited to partner with MBA, the leading distributor of biomedical spine treatment products in Europe and South America," said Dr. John Stalcup, CEO o
'/>"/>

SOURCE Osseon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Osseon Receives CE Mark
2. New device finds early signs of eye disease in preemies
3. GENova Biotherapeutics signs LOI with Korean university for stem cell research and patents sharing
4. GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
5. Haemonetics Signs Comprehensive Agreement with Blood Centers of America
6. GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
7. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
8. HemCon Medical Technologies, Inc. signs exclusive global agreement with Zimmer Dental Inc. to distribute oral surgery dressings
9. Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States
10. Online Sign Making from Genuinesigns.com Just Got Faster, Easier, & Greener with its New Revolutionary System
11. Patient Safety Technologies Signs Contract with Partners HealthCare, to Implement the Safety-Sponge(TM) System at Brigham & Womens Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 A recent article ... developed by a Tokyo clothing store for men with gynecomastia, ... of rectifying or diminishing their problem. Board-certified plastic surgeon Dr. ... the problem. While many people only associate male breasts with ... common condition among men of all ages, often starting in ...
(Date:8/29/2014)... Pursuing its deepest desires to help build families, ... new design that promises to redefine the global surrogacy ... platform has witnessed a 42 percent increase in member ... the FindSurrogateMother.com community is formed by hopeful parents and ... the precious gift of life. , Whether intended parents ...
(Date:8/29/2014)... yesterday by the Mental Health Commission of Canada ... and education that police personnel receive. , "People ... Canada,s police community, and today,s report builds on ... people with mental illnesses," says Queen,s adjunct professor ... in the area of police psychology. "This is ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Today, Gen. ... Anti-Drug Coalitions of America (CADCA) , the nation’s leading ... response to President Obama’s intent to nominate Michael Botticelli ... “CADCA strongly supports President Obama’s decision to nominate Michael ... the ideal person to hold this important position at ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Thirteen ... the prestigious Great 100 Nurses in North ... recognizes nursing excellence and provides scholarships to nursing students ... recognized from Novant Health Presbyterian Medical Center ... Lisa Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Great 100 Honors 13 Novant Health Nurses 2
... Hospitals (UH) Case Medical Center is conducting the first ... "heat therapy" or local radiofrequency energy to treat premature ... to the energy produced by radio waves directed with ... a nerve. Premature ejaculation (PE) affects 20 percent ...
... Research Institute (LRI) today announced the award of 12 ... drive innovation and discover novel approaches to understand and ... diseases lupus. Awarded for the highest-ranked ... topics and multi-disciplinary approaches that mirror the heterogeneity and ...
... Institute (GHI) and Inserm (Institut National de la Sant ... for biomedical research) has discovered that a class of ... in cancer cells also kills the parasite that causes ... new strategy for combating this deadly disease. The ...
... leg ulcers is good quality nursing care and the ... University of Leeds has shown that ultrasound therapy does nothing ... contrary to what had been expected. Traditional methods of nursing ... as well, the authors conclude. "The ,healing energy, of ...
... might be required for maximum anti-tumor activity when ... studies by Vanderbilt-Ingram Cancer Center (VICC) investigators. The ... Proceedings of the National Academy of Sciences ... HER3 receptor limits the effectiveness of two classes ...
... An analysis conducted by Ohio State University cancer ... to the treatment of patients with advanced ovarian cancer ... value of various clinical strategies will be published online ... , The researchers performed a cost-effectiveness analysis looking at ...
Cached Medicine News:Health News:University Hospitals Case Medical Center testing innovative 'heat therapy' for premature ejaculation 2Health News:LRI awards wide-ranging research grants to drive next generation of scientific discovery in lupus 2Health News:LRI awards wide-ranging research grants to drive next generation of scientific discovery in lupus 3Health News:LRI awards wide-ranging research grants to drive next generation of scientific discovery in lupus 4Health News:Malaria's weakest link 2Health News:Laughter really is the best medicine (for leg ulcers) 2Health News:Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies suggest 2Health News:Ohio State study: Targeted ovarian cancer therapy not cost-effective 2Health News:Ohio State study: Targeted ovarian cancer therapy not cost-effective 3
(Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
(Date:8/29/2014)... The Competitive Intelligence (CI) function is evolving ... leaders who adjust will succeed, and those who don,t ... Practices, LLC study CI leaders from 32 biopharmaceutical organizations ... - Use secondary research whenever possible - it,s effective, ... Internal staff who are creative thinkers provide the CI ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2
... peers in examining the rise of adaptive study approaches ... ... 23 Cytel,s renowned adaptive,trial design and implementation experts Cyrus Mehta ... and case,study reviews at the Annual Meeting of the Drug Information ...
... Inc. (Nasdaq: ALXA ) announced today that ... trial of Staccato(R) loxapine (AZ-104) for,the treatment of ... of,the American Headache Society, which being held at ... oral platform abstract presentation,"Inhaled Loxapine, a Dopamine Antagonist, ...
Cached Medicine Technology:Cytel's Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting 2Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting 2
PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
Px2 thermal Cycler chassis (requires block). Multiple interchangeable blocks. Gradient capability. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced r...
Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature...
Medicine Products: